No Data
No Data
Trump Administration Said to Be Investing $500M on Developing Universal Vaccines
Earnings Scheduled For May 1, 2025
Moderna Options Spot-On: On April 30th, 50,904 Contracts Were Traded, With 771K Open Interest
Unusual Options Activity: SMCI, EBAY and Others Attract Market Bets, SMCI V/OI Ratio Reaches 477.3
Preview: Moderna's Earnings
Asthma and HIV drugs drive performance growth. GlaxoSmithKline (GSK.US) Q1 profits exceeded expectations, maintaining the annual performance outlook.
The company's profits in the first quarter exceeded expectations, particularly strong sales of asthma and HIV treatment drugs offset the negative impact of the overall vaccine Business line sales performance being below expectations.